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In current dogma coronary atherosclerosis causes angina.
myocardial infarction and sudden death because it produces
critical and typically fixed proximal narrowings in epicardial
coronary arteries, Severe focal narrowings (>75%) lead to
inadequate blood supply and myocardial ischemia, espe-
cially when flow demands are increased . These focal lesions
are also subject to rupture and fissuring and are the sites of
acute thrombotic occlusion. In this scheme the coronary
arteries are only conduits-rusty pipes-led to their end-
stage pathology as relatively passive victims of dietary
excess and systemic metabolic derangement .
The present
study
. Several studies, including the one by
Nabel et al. (1) in this issue of the Journal, underscore a
more dynamic paradigm to describe the behavior of healthy
and diseased coronary arteries . In the study by Nabel et al .
angiographically normal segments of mildly atherosclerotic
coronary arteries failed to dilate as they should in response
to increased blood flow induced by papavarine ; moreover .
the majority of vessels constricted paradoxically and in-
appropriately . The pathologic response
of these mildly dis-
eased arteries is probably due to endothelial cell dysfunc-
tion because acetylcholine (which induces endothelium-
dependent relaxation) also failed to cause dilation in these
patients, whereas nitrates (which cause smooth muscle
relaxation) caused dilation. Other studies from this group (2)
have shown a similar response in humans with and without
atherosclerosis when flow was increased by adenosine, and
other investigators (3,4) have demonstrated impaired vaso-
dilation of isolated atherosclerotic human coronary and iliac
arteries exposed to acetylcholine and thrombin and n":rtal
dilation with nitrates . These reports indicate that the grow-
ing body of information from the basic laboratory on the
active role of vascular endothelium in regulating vessel
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structure and function is keenly relevant net only to humans
but also to that special human plague, vascular atheroscle-
rosis and ischemic heart disease.
Vasoactive rob
of eudotheBtm. The endothelial cell has
emerged as a major player in vascular health and disease .
Recent studies have shown that the endothelium is a "mini
endocrine gland" (5), that responds to various stimuli by
producing and secreting locally a variety of metabolically
active compounds that act on neighboring cells to produce
an effect-good or bad, Less than a decade ago Furchgott
and Zawadzki (6) showed that endothelial cells were respon-
sible for the vasadilatary effect of acetylcholine and subse-
quent work identified endothelium-derived relaxing factor
(EDRF) as the mediator. EDRF is secreted by endothelium
in response to a variety of stimuli including increased blood
flow . shear stress and several vasoactive peptides (such as
acetylcholine, norepittephrine and serotonin) and acts di•
redly on neighboring vascular smooth muscle to cause
vasoditation . In experimental studies arteries denuded of
endothelium lose their ability to dilate in response to these
stimuli . Thus, FDRF is the blood vessels' own locally
produced "nitroglycerin," causing the underlying vascular
smooth muscle to relax when there is a call for more blood
flow, Because mildly diseased vessels with intact endothe-
lium seem to lose the ability to dilate in response to endo-
thelium-dependent relaxing stimuli, it is
likely that, under
some circumstances, endothelium becomes dysfunctional,
that is. loses the ability either to sense the appropriate
stimuli or to synthesize or secrete its local hormone.
Rob of eadotkeliat dys[unctloa in atherosclersis . The
cause of the endothelial dysfunction in the patients studied
by Nobel et al. (I) seems to be
atherosclerosis . Yet the
coronary segments that showed impaired response to in-
creased flow were, for the most part, angiographically nor-
mal. One explanation may be that the vessels were athero-
sclerotic but the lesions not extensive enough to
be detected
angiographically
. Alternatively; the vascular segments may
not be involved tangibly in atherosclerosis but preathero-
sclerotic factors may be operative. That is, the precursor
state of atherosclerosis in which endothelial cells undergo
metabolic alterations may be
associated with dysfunction
marked in part by impaired ability to produce EDRF
. The
latter possibility is supported by the recent studies of Sellke
ct al. (7), who demonstrated similar endothelial cell dysfunc-
tion in the microcitruiafion of hypercholesterolemic pri-
mates . In their atherosclerotic primates, which had been on
a high cholesterol d:etfor If months, acetylcholine produced
paradoxic contraction of the microcirculation but normal
microvascular responses to smooth muscle vasodilators .
The coronary microvessels were essentially normal morpho-
logically despite atherosclerosis of the epicardial coronary
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arteries
. Although the coronary microvasculature is not
susceptible to atherosclerosis, the study by Sellke et al . (7)
suggests that hypercholesterolemia in itself induced in these
seemingly normal vessels endothelial dysfunction similar to
that seen in atherosclerotic vessels . Alternatively, normal
segments may somehow become impaired by being part of a
structurally or functionally diseased vessel .
Role in myocardial ischemia. The loss of endothelium-
dependent relaxation, whether it be in the larger conduit
epicardial coronary arteries with atherosclerosis or at the
microvascular level where atherosclerosis does not occur,
would be detrimental to myocardial perfusion, particularly
when the organ is stressed . Specific clinical consequences of
impaired endothelial relaxation responses ill the macro- or
microvasculature have not been defined, but these current
studies in humans suggest that impaired EDRF release and
paradoxic constriction of coronary arteries might well play a
role in aggravation of ischemia in patients with atheroscle-
rosis, particularly when there is a demand for increased
blood flow, as with exercise or during stress. Coronary
spasm, known to often accompany acute ischemic syn-
dromes in patients with coronary atherosclerosis (including
acute myocardial infarction and unstable angina), may be
due in part to the inability of the impaired endothelium to
secrete its protective vasodilator EDRF. Endothelial cell
dysfunction may also be a component of isolated coronary
artery spasm inducing ischemia .
Other endothelial endocrine imbalances . Although im-
paired EDRF production seems a likely cause of inappropri-
ate constriction, other endocrine imbalances of the endothe-
lial cell should also be mentioned as candidates
. For
example, dysfunctional endothelium may produce excess
amounts of endothelium-derived vasoconstrictors . Endothe-
lin is a recently discovered, highly po`^nt vasoconstricting
peptide produced by endothelial echo (8). Experimental
evidence indicates that endothelial cell production of endo-
thelin is increased when vessels are injured and that the
effect on the blood vessel is both contraction and cell
proliferation. Also, vasoconstricting hormones, such as en-
dothelin or norepinephrine, may exert a net constricting
effect on underlying vascular smooth muscle, especially
when those effects are unopposed by normal production of
EDRF.
Role in progression of
atherosclerosis. Progression of ath-
erosclerosis may be a long-term clinical consequence of
endothelial cell dysfunction. The studies on the microcircu-
lation by Sellke et al
. (7) and those of Nobel et al . (1) show
that endothelium of vessels that are not directly involved
with atherosclerosis may function abnormally when part of a
vasculature with atherosclerotic lesions elsewhere. Clearly,
if arterial segments deprived of a normal EDRF response
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(with or without atherosclerosis) do not increase in diameter
in response to increased flow, and some even paradoxically
constrict, the effect is increased shear stress, increased
turbulent flow and a greaser likelihood of endothelial injury
predisposing to atherosclerotic progression . Because EDRF
also has antithrombotic effects (9), its loss or decrease would
further aggravate the process. Endothelial cells that are
injured trigger thrombotic events and give contractile signals
and also begin to produce growth factors, specifically plate-
let-derived growth factor, which stimulates smooth muscle
cells and fibroblasts to proliferate and probably plays a key
role in the development and progression of atherosclerosis
(5).
EDRF and endothelium-derived constricting factor (en-
dothelia) are local hormones that regulate vessel function .
Endothelium-derived growth factors (platelet-derived
growth factor and possibly endothelin) regulate vessel struc-
ture. Understanding of vascular disease-coronary spasm,
acute coronary occlusion and the end-stage atherosclerotic
lesion-will be intimately related to detailed knowledge of
the endothelial cell as an endocrine gland . Prevention and
treatment will be linked to pharmacologic and other kinds of
interventions that can correct these local "endocrine" im-
balances.
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